These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28699773)

  • 21. Evaluation of ephedrine, pseudoephedrine and phenylpropanolamine concentrations in human urine samples and a comparison of the specificity of DRI amphetamines and Abuscreen online (KIMS) amphetamines screening immunoassays.
    Stout PR; Klette KL; Horn CK
    J Forensic Sci; 2004 Jan; 49(1):160-4. PubMed ID: 14979364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse.
    Beck O; Rausberg L; Al-Saffar Y; Villen T; Karlsson L; Hansson T; Helander A
    Drug Test Anal; 2014 May; 6(5):492-9. PubMed ID: 24665024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accidental intoxications in toddlers: lack of cross-reactivity of vilazodone and its urinary metabolite M17 with drug of abuse screening immunoassays.
    Martinez-Brokaw CD; Radke JB; Pierce JG; Ehlers A; Ekins S; Wood KE; Maakestad J; Rymer JA; Tamama K; Krasowski MD
    BMC Clin Pathol; 2019; 19():2. PubMed ID: 30820187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Cross-Reactivity of Fenofibric Acid With MDMA DRI Assay.
    Bugier S; Garcia-Hejl C; Vest P; Plantamura J; Chianea D; Renard C
    Mil Med; 2016 Sep; 181(9):1013-5. PubMed ID: 27612346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-reactivity studies and predictive modeling of "Bath Salts" and other amphetamine-type stimulants with amphetamine screening immunoassays.
    Petrie M; Lynch KL; Ekins S; Chang JS; Goetz RJ; Wu AH; Krasowski MD
    Clin Toxicol (Phila); 2013 Feb; 51(2):83-91. PubMed ID: 23387345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The urinary screening and identification of amphetamines in clinical toxicology laboratory--VGH].
    Lin WL; Deng JF; Chou LJ; Hung DZ; Tsai WJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Oct; 48(4):305-9. PubMed ID: 1659927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranitidine interference with standard amphetamine immunoassay.
    Liu L; Wheeler SE; Rymer JA; Lower D; Zona J; Peck Palmer OM; Tamama K
    Clin Chim Acta; 2015 Jan; 438():307-8. PubMed ID: 25242739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Urine Drug Testing in the Current Opioid Epidemic.
    Mahajan G
    Anesth Analg; 2017 Dec; 125(6):2094-2104. PubMed ID: 29189366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An audit of the effectiveness of amphetamine isomer ratios as a marker of Dexedrine compliance in amphetamine abusers.
    George S
    Addict Biol; 2003 Dec; 8(4):439-43. PubMed ID: 14690880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.
    Moeller KE; Kissack JC; Atayee RS; Lee KC
    Mayo Clin Proc; 2017 May; 92(5):774-796. PubMed ID: 28325505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Method comparison of the Ortho Vitros Fusion 5,1 chemistry analyzer and the Roche COBAS Integra 400 for urine drug screen testing in the emergency department.
    Johnson-Davis KL; Thompson CD; Clark CJ; McMillin GA; Lehman CM
    J Anal Toxicol; 2012 Jun; 36(5):345-8. PubMed ID: 22582270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation between blood- and urine-amphetamine concentrations in impaired drivers as influenced by urinary pH and creatinine.
    Jones AW; Karlsson L
    Hum Exp Toxicol; 2005 Dec; 24(12):615-22. PubMed ID: 16408614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical impact of a false-positive urine cocaine screening result on a patient's pain management.
    Kim JA; Ptolemy AS; Melanson SE; Janfaza DR; Ross EL
    Pain Med; 2015 Jun; 16(6):1073-6. PubMed ID: 24138673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Underreporting of illicit drug use by patients at emergency departments as revealed by two-tiered urinalysis.
    Chen WJ; Fang CC; Shyu RS; Lin KC
    Addict Behav; 2006 Dec; 31(12):2304-8. PubMed ID: 16564643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous Determination of Amphetamine-Related New Psychoactive Substances in Urine by Gas Chromatography-Mass Spectrometry.
    Kim JY; Suh S; Park J; In MK
    J Anal Toxicol; 2018 Nov; 42(9):605-616. PubMed ID: 29982540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. False positive urine amphetamine immunoassay due to solriamfetol.
    Kumar G; Auckley D; Merrick T; Breckenridge M; Carter JC; Ali M
    Sleep Med; 2023 Oct; 110():297-299. PubMed ID: 37708619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphetamine positive toxicology screen secondary to bupropion.
    Weintraub D; Linder MW
    Depress Anxiety; 2000; 12(1):53-4. PubMed ID: 10999247
    [No Abstract]   [Full Text] [Related]  

  • 38. Routine Drug Screening for Patients in the Emergency Department of a State Psychiatric Hospital: A Naturalistic Cohort Study.
    Margolis A; Rosca P; Kurs R; Sznitman SR; Grinshpoon A
    J Dual Diagn; 2016; 12(3-4):218-226. PubMed ID: 27779447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acute poisoning with weight-loss dietary supplement falsely suggesting the use of amphetamine].
    Łukasik-Głebocka M; Sommerfeld K; Tezyk A; Zielińska-Psuja B
    Przegl Lek; 2013; 70(10):880-3. PubMed ID: 24501816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.